Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M127979-5mg | 5mg | In stock | $98.90 | |
M127979-10mg | 10mg | In stock | $167.90 | |
M127979-25mg | 25mg | In stock | $378.90 | |
M127979-50mg | 50mg | In stock | $444.90 | |
M127979-100mg | 100mg | In stock | $741.90 | |
M127979-200mg | 200mg | In stock | $1,335.90 |
Synonyms | MK-5108|1010085-13-8|VX-689|MK 5108|MK5108|MK-5108 (VX-689)|VX689|VX 689|4-(3-chloro-2-fluorophenoxy)-1-[[6-(1,3-thiazol-2-ylamino)pyridin-2-yl]methyl]cyclohexane-1-carboxylic acid|(1r,4r)-4-(3-chloro-2-fluorophenoxy)-1-((6-(thiazol-2-ylamino)pyridin-2-yl |
---|---|
Specifications & Purity | ≥98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Serine/threonine-protein kinase Aurora-A inhibitor |
ALogP | 5.4 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488200675 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488200675 |
IUPAC Name | 4-(3-chloro-2-fluorophenoxy)-1-[[6-(1,3-thiazol-2-ylamino)pyridin-2-yl]methyl]cyclohexane-1-carboxylic acid |
INCHI | InChI=1S/C22H21ClFN3O3S/c23-16-4-2-5-17(19(16)24)30-15-7-9-22(10-8-15,20(28)29)13-14-3-1-6-18(26-14)27-21-25-11-12-31-21/h1-6,11-12,15H,7-10,13H2,(H,28,29)(H,25,26,27) |
InChi Key | LCVIRAZGMYMNNT-UHFFFAOYSA-N |
Canonical SMILES | C1CC(CCC1OC2=C(C(=CC=C2)Cl)F)(CC3=NC(=CC=C3)NC4=NC=CS4)C(=O)O |
Isomeric SMILES | C1CC(CCC1OC2=C(C(=CC=C2)Cl)F)(CC3=NC(=CC=C3)NC4=NC=CS4)C(=O)O |
PubChem CID | 24748204 |
Molecular Weight | 461.94 |
PubChem CID | 24748204 |
---|---|
CAS Registry No. | 1010085-13-8 |
ChEMBL Ligand | CHEMBL3182444 |
PubChem SID | 488200675 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
F2325084 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325098 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325096 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325094 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325093 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325092 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325090 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325089 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325088 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325087 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325086 | Certificate of Analysis | May 29, 2023 | M127979 |
F2325085 | Certificate of Analysis | May 29, 2023 | M127979 |
D2321866 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321986 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321979 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321973 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321969 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321964 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321963 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321944 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321890 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321889 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321888 | Certificate of Analysis | Mar 20, 2023 | M127979 |
D2321878 | Certificate of Analysis | Mar 20, 2023 | M127979 |
Solubility | DMSO 92 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
---|
Starting at $311.90
1. Shimomura T, Hasako S, Nakatsuru Y, Mita T, Ichikawa K, Kodera T, Sakai T, Nambu T, Miyamoto M, Takahashi I et al.. (2010) MK-5108, a highly selective Aurora-A kinase inhibitor, shows antitumor activity alone and in combination with docetaxel.. Mol Cancer Ther, 9 (1): (157-66). [PMID:20053775] |
2. Willemsen-Seegers N, Uitdehaag JCM, Prinsen MBW, de Vetter JRF, de Man J, Sawa M, Kawase Y, Buijsman RC, Zaman GJR. (2017) Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance.. J Mol Biol, 429 (4): (574-586). [PMID:28043854] |